Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Dominika Klimczak-Tomaniak"'
Autor:
Julia Haponiuk-Skwarlińska, Agata Antoniak, Michalina Ciurla, Katarzyna Paluch, Gabriela Makulec, Dominika Klimczak-Tomaniak, Marek Kuch, Maciej Janiszewski
Publikováno v:
International Journal of Occupational Medicine and Environmental Health, Vol 36, Iss 6, Pp 732-743 (2023)
Objectives To assess dietary supplements, functional foods and nutraceuticals use among the patients after myocardial infarction (MI). Material and Methods The authors prospectively enrolled 100 consecutive patients hospitalized due to MI and remain
Externí odkaz:
https://doaj.org/article/150e698e15c645e699e4bf8c1183ca97
Autor:
Karolina Gumiężna MD, Piotr Baruś MD, Grażyna Sygitowicz PhD, Agnieszka Wiśniewska PhD, Adrian Bednarek MS, Jakub Zabłocki MS, Adam Piasecki MS, Dominika Klimczak-Tomaniak MD, PhD, Janusz Kochman MD, PhD, Marcin Grabowski MD, PhD, Mariusz Tomaniak MD, PhD
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 29 (2024)
Objective: Platelets are strongly associated with cardiovascular events due to their role in thrombotic processes. Reticulated platelets have higher prothrombotic potential. The aim of the study was to evaluate the effectiveness of immature platelet
Externí odkaz:
https://doaj.org/article/9f3791e80e1c407192496f6ba699ad7d
Autor:
Dominika Klimczak-Tomaniak, Marie de Bakker, Elke Bouwens, K. Martijn Akkerhuis, Sara Baart, Dimitris Rizopoulos, Henk Mouthaan, Jan van Ramshorst, Tjeerd Germans, Alina Constantinescu, Olivier Manintveld, Victor Umans, Eric Boersma, Isabella Kardys
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract The aim of our observational study was to derive a small set out of 92 repeatedly measured biomarkers with optimal predictive capacity for adverse clinical events in heart failure, which could be used for dynamic, individual risk assessment
Externí odkaz:
https://doaj.org/article/9bff43d637134a2ea782a613c9c9c664
Autor:
Dominika Klimczak‐Tomaniak, Elke Bouwens, Anne‐Sophie Schuurman, K. Martijn Akkerhuis, Alina Constantinescu, Jasper Brugts, B. Daan Westenbrink, Jan vanRamshorst, Tjeerd Germans, Leszek Pączek, Victor Umans, Eric Boersma, Isabella Kardys
Publikováno v:
ESC Heart Failure, Vol 7, Iss 3, Pp 1190-1200 (2020)
Abstract Aims Evidence on the association of macrophage‐ and neutrophil‐related blood biomarkers with clinical outcome in heart failure patients is limited, and, with the exception of C‐reactive protein, no data exist on their temporal evolutio
Externí odkaz:
https://doaj.org/article/3f632ab400da4cda8948b6e226494fae
Autor:
Stefan Roest, Dennis A. Hesselink, Dominika Klimczak‐Tomaniak, Isabella Kardys, Kadir Caliskan, Jasper J. Brugts, Alexander P.W.M. Maat, Michał Ciszek, Alina A. Constantinescu, Olivier C. Manintveld
Publikováno v:
ESC Heart Failure, Vol 7, Iss 2, Pp 533-541 (2020)
Abstract Aims Many heart transplant recipients will develop end‐stage renal disease in the post‐operative course. The aim of this study was to identify the long‐term incidence of end‐stage renal disease, determine its risk factors, and invest
Externí odkaz:
https://doaj.org/article/f8010153f8fd4368824709d0d03683ff
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 23, p 15013 (2022)
Heart failure is defined as a clinical syndrome consisting of key symptoms and is due to a structural and/or functional alteration of the heart that results in increased intracardiac pressures and/or inadequate cardiac output at rest and/or during ex
Externí odkaz:
https://doaj.org/article/ab4d14e166d54878af86bea494c94865
Autor:
Monika, Wrzosek, Anna, Hojka-Osińska, Dominika, Klimczak-Tomaniak, Anna Katarzyna, Żarek-Starzewska, Wioletta, Dyrla, Magdalena, Rostek-Bogacka, Maksym, Wróblewski, Marek, Kuch, Magdalena, Kucia
Publikováno v:
Advances in Clinical and Experimental Medicine. 32:125-130
Diabetic patients present an increased risk for heart failure (HF) independently of the presence of coronary artery disease (CAD) and hypertension. However, little is known about circulatory microRNA (miRNA), an important regulatory RNA in this popul
Autor:
Karolina Gumiężna, Piotr Baruś, Grażyna Sygitowicz, Agnieszka Wiśniewska, Dorota Ochijewicz, Karolina Pasierb, Dominika Klimczak-Tomaniak, Ewa Kuca-Warnawin, Janusz Kochman, Marcin Grabowski, Grzegorz Opolski, Mariusz Tomaniak, Krzysztof J. Filipiak
Publikováno v:
Cardiology Journal.
Autor:
Monika Wrzosek, Anna Hojka-Osińska, Dominika Klimczak-Tomaniak, Anna Katarzyna Żarek-Starzewska, Wioletta Dyrla, Magdalena Rostek-Bogacka, Maksym Wróblewski, Marek Kuch, Magdalena Kucia
Supplementary Material Text S1. Supplemental methods - study population Text S2. Supplemental methods - statistical analysis Figure S1.Explorative analysis of serum miRNA accumulation profile in heart failure patients. Figure S2. Profiling of serum m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e50a5425730c289d39f4b39b7ee73b10
Publikováno v:
Journal of clinical medicine. 11(7)
Micro-ribonucleic acids (microRNAs) are small molecules that take part in the regulation of gene expression. Their function has been extensively investigated in cardiovascular diseases (CVD). Most recently, miRNA expression levels have been suggested